# Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

> **NCT01828697** · PHASE4 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 1110 (actual)

## Conditions studied

- Deep Venous Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Low dose nadroparin
- **DRUG:** Intermediate dose nadroparin
- **DRUG:** Low dose enoxaparin
- **DRUG:** Intermediate dose enoxaparin
- **DRUG:** Low dose dalteparin
- **DRUG:** Intermediate dose dalteparin
- **DRUG:** Fixed low dose tinzaparin
- **DRUG:** Intermediate dose tinzaparin

## Key facts

- **NCT ID:** NCT01828697
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-24
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 1110 (ACTUAL)
- **Last updated:** 2022-05-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01828697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01828697, "Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01828697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*